No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.

No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.

BACKGROUND:Although Lactobacillus rhamnosus GG ATCC 53103 (LGG) has been consumed by 2 to 5 million people daily since the mid 1990s, there are few clinical trials describing potential harms of LGG, particularly in the elderly. OBJECTIVES:The primary objective of this open label clinical trial is to...

Full description

Bibliographic Details
Main Authors: Patricia L Hibberd, Lauren Kleimola, Anne-Maria Fiorino, Christine Botelho, Miriam Haverkamp, Irina Andreyeva, Debra Poutsiaka, Claire Fraser, Gloria Solano-Aguilar, David R Snydman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4249962?pdf=render

Internet

http://europepmc.org/articles/PMC4249962?pdf=render

Similar Items